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Background
Autopsy studies report a cardiac involvement in sarcoi-
dosis as high as 20-60%. Clinically a much lower detec-
tion rate of approximately 5% has been reported. Since
cardiac events are the second most frequent cause of
death, a high rate of undetected cases of cardiac involve-
ment can be presumed, potentially leading to a fatal
event as the fist manifestation. Previous studies have
shown the superiority of CMR to detect cardiac involve-
ment in sarcoidosis compared to other imaging modal-
ities or clinical scores. We aimed at investigating the
prevalence of previously unknown cardiac involvement
in sarcoidosis in a caucasian population.
Methods
The local institutional review board approved this pro-
spective study. Patients were recruited through a nation-
wide patient support group and the local pulmonology
department.
Only patients with histologically proven sarcoidosis,
but without previously known cardiac involvement fol-
lowing routine clinical assessment were included. The
CMR protocol included SSFP cine images covering the
entire left ventricle, early relative contrast enhancement,
T2 STIR imaging in the short axis orientation as well as
delayed enhancement imaging covering the standard
cardiac axes. Two experienced readers, blinded to all
clinical data, analyzed the CMR studies.
Results
During the first recruitment period from August 2011
through February 2012 a total of 90 patients were
included into the study (58 females) with a mean age of
52 years (median 52).
The mean duration since diagnosis of sarcoidosis was
115 months (median 80 months). In this population
extranodal and extrapulmonary manifestation were pre-
sent in the skin (22.2%), in the liver (8.8%), in the eye
(16.6%) and in the central nervous system (7.7%). Global
cardiac function parameters were as follows: LVEDV
112ml, IVSD 10mm, LVEF 68%.
CMR revealed previously unknown cardiac involve-
ment in 7/90 Patients (7.8%) (figure demonstrating typi-
cal enhancement pattern and regional edema in one
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Figure 1 From left to right (arrows): Short axis T2 Stir showing edema. Short and vertical long axis showing necrosis.
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patient). The diagnosis was based on the presence of
typical delayed enhancement (n=5) or early gadolinium
enhancement plus wall motion abnormality or pericar-
dial effusion. Patients with cardiac involvement did not
demonstrate a reduction of global cardiac function com-
pared to the patients without cardiac involvement:
LVEDV 111ml, IVSD 10mm, LVEF 69%.
Conclusions
In this preliminary study in 90 patients CMR detected
seven cases of cardiac involvement in sarcoidosis (7.8%),
missed by standard clinical testing. This finding suggests
a potential role for CMR in the routine workup of sar-
coidosis patients, but warrants further investigation to
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